Innoviva, Inc. (INVA) Executive Compensation
Innoviva, Inc. (INVA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INVA
CIK: 1080014
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJonathan Margate
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363611 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363610 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363608 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335235 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335192 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001410 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236913 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236910 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236907 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | 4 | 0001193125-26-232638 | View SEC Doc Filr Page |
| 3 | 2026-05-20 | 2026-05-18 | 3 | 0001193125-26-232616 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-12 | 8-K | 0001193125-26-228958 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-060384 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001193125-26-209110 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001193125-26-209044 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209015 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209009 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209007 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209006 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209005 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209003 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209001 | View SEC Doc Filr Page |
| S-8 | 2026-05-04 | — | S-8 | 0001193125-26-204249 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001193125-26-204243 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002100121-26-000427 | View SEC Doc Filr Page |